Liu Jun, Yadav Sandeep, Andya James, Demeule Barthélemy, Shire Steven J
Late Stage Pharamaceutical and Processing Development, Genentech.
Late Stage Pharamaceutical and Processing Development, Genentech.
Methods Enzymol. 2015;562:441-76. doi: 10.1016/bs.mie.2015.04.008. Epub 2015 Aug 3.
The historical contributions of analytical ultracentrifugation (AUC) to modern biology and biotechnology drug development and research are discussed. AUC developed by Svedberg was used to show that proteins are actually large defined molecular entities and also provided the first experimental verification for the semiconservative replication model for DNA initially proposed by Watson and Crick. This chapter reviews the use of AUC to investigate molecular weight of recombinant-DNA-produced proteins, complex formation of antibodies, intermolecular interactions in dilute and high concentration protein solution, and their impact on physical properties such as solution viscosity. Recent studies using a "competitive binding" analysis by AUC have been useful in critically evaluating the design and interpretation of surface plasmon resonance measurements and are discussed. The future of this technology is also discussed including prospects for a new higher precision analytical ultracentrifuge.
本文讨论了分析超速离心技术(AUC)对现代生物学以及生物技术药物开发与研究的历史贡献。由斯韦德贝里发明的AUC技术被用于证明蛋白质实际上是具有明确结构的大分子实体,同时也为最初由沃森和克里克提出的DNA半保留复制模型提供了首个实验验证。本章回顾了利用AUC技术研究重组DNA生产的蛋白质的分子量、抗体的复合物形成、稀溶液和高浓度蛋白质溶液中的分子间相互作用,以及它们对诸如溶液粘度等物理性质的影响。最近利用AUC进行“竞争性结合”分析的研究对于严格评估表面等离子体共振测量的设计和解释很有帮助,本文对此也进行了讨论。此外,还探讨了该技术的未来发展,包括新型高精度分析超速离心机的前景。